Clinical Neuropathology QUIZ #18
Published in Clinical Neuropathology Vol 42 nr.2 (March-April 2023). Based on papers and editorial of Clinical Neuropathology of the same issue: https://www.dustri.com/nc/journals-in-english/mag/clinical-neuropathology/vol/volume-42-2023/issue/marchapril-17.html
Sign in to Google to save your progress. Learn more

1. Which of the following tumors have to be considered as histological differential diagnosis for olfactory neuroblastoma?

*
1 point

2. Which of the following sarcomas is newly included in the 5th edition of the WHO classification of tumors? 

*
1 point

3. Which of the following statements regarding the expression of PD-1 in olfactory neuroblastoma is correct?

*
1 point

4. Which of the following diseases are caused by triplet repeat expansions?
*
1 point

5. Which of the following sarcomas has the highest incidence in the CNS?

*
1 point

6. Which of the following is a sensitive immunohistochemical marker for Ewing sarcoma?

*
1 point
Submit
Clear form
This form was created inside of Euro-CNS. Report Abuse